drugset / Trial / NCT00119691
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
RandomizedParallel-groupOpen-labelTreatment
Summary
The researchers hypothesize that the addition of nesiritide to standard therapy will prevent worsening of renal function in patients admitted to the hospital with decompensated heart failure and renal dysfunction relative to standard therapy alone.
Timeline
- Start
- 2003-04
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nesiritide | Protein / enzyme biologic | 0.03 ug/kg | — |